
Книги фарма 2 / Bertram G. Katzung-Basic & Clinical Pharmacology(9th Edition)
.pdfAntifungal |
Butenafine, 1% |
|
Lotrimin Ultra |
|
Effective for the treatment of |
|
||
topical |
(cream) apply to |
|
|
|
|
tinea pedis (athlete's foot), |
|
|
preparations |
affected areas once |
|
|
|
|
tinea cruris (jock itch), and |
|
|
|
daily |
|
|
|
|
tinea corporis (ringworm). |
|
|
|
|
|
|
|
|
|
Clotrimazole and miconazole |
|
|
Clotrimazole, 1% |
|
|
Lotrimin AF |
|
|||
|
|
|
|
|
also effective against |
|
||
|
(cream, lotion, |
|
|
Cream/Lotion/Solution, |
|
|
|
|
|
solution), apply to |
|
|
Mycelex OTC |
|
|
Candida albicans. |
|
|
|
|
|
|
|
|
||
|
affected areas twice |
|
|
|
|
|
|
|
|
daily |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Miconazole, 2% |
|
|
Lotrimin AF |
|
|
|
|
|
(cream, powder, |
|
|
Powder/Spray, Micatin, |
|
|
|
|
|
solution), apply to |
|
|
Zeasorb-AF |
|
|
|
|
|
affected areas twice |
|
|
|
|
|
|
|
|
daily |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Terbinafine, 1% |
|
|
Lamisil AT |
|
|
|
|
|
(cream), apply to |
|
|
|
|
|
|
|
|
affected areas once or |
|
|
|
|
|
|
|
|
twice daily |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tolnaftate, 1% (cream, |
|
|
Aftate, Tinactin, Ting, |
|
|
|
|
|
powder, solution), |
|
|
various generic |
|
|
|
|
|
apply to affected areas |
|
|
|
|
|
|
|
|
twice daily |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Undecylenic acid, 10– |
|
|
Cruex, Desenex, various |
|
|
|
|
|
25% (powder, spray |
|
|
generic |
|
|
|
|
|
powder, cream, liquid) |
|
|
|
|
|
|
|
|
apply to affected areas |
|
|
|
|
|
|
|
|
twice daily |
|
|
|
|
|
|
|
Antifungal |
Butoconazole, 2% |
|
|
Femstat-3, Mycelex-3 |
|
|
Topical vaginal antifungals |
|
vaginal |
cream, one |
|
|
|
|
|
should only be used for |
|
preparations |
applicatorful |
|
|
|
|
|
treatment of recurrent |
|
|
intravaginally at |
|
|
|
|
|
vulvovaginal candidiasis |
|
|
bedtime for 3 |
|
|
|
|
|
previously diagnosed by a |
|
|
consecutive days |
|
|
|
|
|
clinician in otherwise |
|
|
|
|
|
|
|
|
healthy, nonpregnant women. |
|
|
|
|
|
|
|
|
|
|
|
Clotrimazole (1%, 2% |
|
|
Gyne-Lotrimin, |
|
|
Insert one applicatorful (1%) |
|
|
vaginal cream, 100 mg, |
|
|
Mycelex-7, Gyne- |
|
|
or one tablet (100 mg) |
|
|
200 mg tablet); see |
|
|
Lotrimin-3, various |
|
|
intravaginally at bedtime for |
|
|
comments for dosage |
|
|
generic |
|
|
7 consecutive days. |
|
|
|
|
|
|
|
|
Alternatively: Insert one |
|
|
|
|
|
|
|
|
applicatorful (2%) or one |
|
|
|
|
|
|
|
|
tablet (200 mg), |
|
|
|
|
|
|
|
|
intravaginally at bedtime for |
|
|
|
|
|
|
|
|
3 consecutive days. |
|
|
|
|
|
|
|
|
|
|
|
Miconazole (2%, 4% |
|
|
Monistat-7, Monistat-3 |
|
|
Insert one applicatorful |
|
|
vaginal cream; 100 mg, |
|
|
|
|
|
intravaginally at bedtime for |
|
|
200 mg vaginal |
|
|
|
|
|
7 consecutive days (2%) or 3 |
|
|
suppositories); see |
|
|
|
|
|
consecutive days (4%). |
|
|
comments for dosage |
|
|
|
|
|
Alternatively: insert one |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
suppository intravaginally at |
||
|
|
|
|
|
|
|
bedtime for 7 consecutive |
||
|
|
|
|
|
|
|
days (100 mg) or 3 |
||
|
|
|
|
|
|
|
consecutive days (200 mg). |
||
|
|
|
|
|
|
|
|
|
|
|
Tioconazole, 6.5% |
|
|
Monistat-1, Vagistat-1 |
|
|
|
|
|
|
vaginal ointment, one |
|
|
|
|
|
|
|
|
|
applicatorful |
|
|
|
|
|
|
|
|
|
intravaginally at |
|
|
|
|
|
|
|
|
|
bedtime (single-dose) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti- |
Hydrocortisone, 0.5% |
|
|
Anusol HC, Cortaid, |
|
|
Used to temporarily relieve |
|
|
inflammatory |
(cream, ointment, |
|
|
Cortizone-5, Cortizone- |
|
|
itching and inflammation |
|
|
topical |
lotion), 1% (cream |
|
|
10, various generic |
|
|
associated with minor rashes |
|
|
preparations |
ointment, lotion, spray) |
|
|
|
|
|
due to contact or allergic |
|
|
|
|
|
|
|
|
|
dermatitides, insect bites, and |
|
|
|
|
|
|
|
|
|
hemorrhoids. Apply sparingly |
|
|
|
|
|
|
|
|
|
to affected areas two to four |
|
|
|
|
|
|
|
|
|
times daily. |
|
|
Antiseborrheal |
Coal tar, 0.5-15% |
|
|
Denorex, Ionil T Plus, |
|
|
Tar derivatives inhibit |
|
|
agents |
shampoo, dosage |
|
|
Tegrin, Zetar, various |
|
|
epidermal proliferation and |
|
|
|
varies; consult product |
|
|
generic |
|
|
may possess antipruritic and |
|
|
|
labeling |
|
|
|
|
|
antimicrobial activity. |
|
|
|
|
|
|
|
|
|
|
|
|
|
Ketoconazole, 1% |
|
|
Nizoral A-D |
|
|
Synthetic azole antifungal |
|
|
|
shampoo, apply every |
|
|
|
|
|
agent with activity versus |
|
|
|
3–4 days |
|
|
|
|
|
Pityrosporum ovale, a fungus |
|
|
|
|
|
|
|
|
|
that may cause seborrhea and |
|
|
|
|
|
|
|
|
|
dandruff. Massage over entire |
|
|
|
|
|
|
|
|
|
scalp for 3 minutes. Rinse |
|
|
|
|
|
|
|
|
|
thoroughly and repeat |
|
|
|
|
|
|
|
|
|
application. |
|
|
|
Pyrithione zinc, 1–2% |
|
|
Denorex, Head & |
|
|
Both selenium sulfide and |
|
|
|
shampoo, apply once |
|
|
Shoulders, Sebulon, |
|
|
zinc pyrithione are cytostatic |
|
|
|
or twice weekly |
|
|
various generic |
|
|
agents that decrease |
|
|
|
|
|
|
|
|
|
epidermal turnover rates. |
|
|
|
Selenium sulfide, 1% |
|
|
Head & Shoulders |
|
|
|||
|
|
|
|
|
Massage into wet scalp for 2– |
|
|
||
|
shampoo, apply once |
|
|
Intensive Treatment, |
|
|
|
|
|
|
|
|
|
|
3 minutes. Rinse thoroughly |
|
|
||
|
or twice weekly |
|
|
Selsun Blue, various |
|
|
|
|
|
|
|
|
|
|
and repeat application. |
|
|
||
|
|
|
|
generic |
|
|
|
|
|
|
|
|
|
|
|
Selenium sulfide can be |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
irritating to the eyes and skin. |
|
|
|
|
|
|
|
|
|
|
|
|
Antitussives |
Codeine, 10–20 mg |
|
|
Robitussin A-C, Guiatuss |
|
|
Acts centrally to increase the |
|
|
|
every 4–6 hours (with |
|
|
AC, various generic |
|
|
cough threshold. In doses |
|
|
|
guaifenesin) |
|
|
|
|
|
required for cough |
|
|
|
|
|
|
|
|
|
suppression, the addictive |
|
|
|
|
|
|
|
|
|
liability associated with |
|
|
|
|
|
|
|
|
|
codeine is low. Many |
|
|
|
|
|
|
|
|
|
codeine-containing |
|
|
|
|
|
|
|
|
|
antitussive combinations are |
|
|
|
|
|
|
|
|
|
schedule V narcotics, and |
|
|
|
|
|
|
|
|
|
OTC sale is restricted in |
|
|
|
|
|
|
|
|
|
some states. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dextromethorphan, |
|
Benylin Adult Formula |
|
Dextromethorphan is a |
||||
|
|
|
10–20 mg every 4 |
|
Cough, Hold DM, Vicks |
|
nonopioid congener of |
||||
|
|
|
hours or 30 mg every |
|
44 Cough Relief, various |
|
levorphanol without |
||||
|
|
|
6–8 hours |
|
generic |
|
analgesic or addictive |
||||
|
|
|
|
|
|
|
|
|
properties. Often is used with |
||
|
|
|
|
|
|
|
|
|
antihistamines, |
||
|
|
|
|
|
|
|
|
|
decongestants, and |
||
|
|
|
|
|
|
|
|
|
expectorants in combination |
||
|
|
|
|
|
|
|
|
|
products. |
||
|
Decongestants, |
|
Oxymetazoline, 0.05% |
|
|
Afrin, Dristan 12 Hour |
|
|
Topical sympathomimetics |
|
|
|
topical |
|
nasal solution, 2–3 |
|
|
Nasal, Neo-Synephrine |
|
|
are effective for the |
|
|
|
|
|
sprays per nostril every |
|
|
12 Hour, various generic |
|
|
temporary acute management |
|
|
|
|
|
10–12 hours |
|
|
|
|
|
of rhinorrhea associated with |
|
|
|
|
|
|
|
|
|
|
|
common colds and allergies. |
|
|
|
|
|
Phenylephrine |
|
|
Neo-Synephrine, various |
|
||||
|
|
|
(0.125%, 0.25%, 0.5%, |
|
|
generic |
|
|
Long-acting agents |
|
|
|
|
|
|
|
|
|
(oxymetazoline and |
|
|
||
|
|
|
1%), nasal solution, 2– |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
xylometazoline) are generally |
|
|
|
|
|
|
3 sprays/drops per |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
preferred, though |
|
|
|
|
|
|
nostril every 3–4 hours |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
phenylephrine is equally |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Xylometazoline |
|
|
Otrivin |
|
||||
|
|
|
|
|
|
|
effective. Topical |
|
|
||
|
|
|
(0.05%, 0.1%), nasal |
|
|
|
|
|
decongestants should not be |
|
|
|
|
|
solution, 2–3 |
|
|
|
|
|
used for longer than 3 days to |
|
|
|
|
|
sprays/drops per nostril |
|
|
|
|
|
prevent rebound nasal |
|
|
|
|
|
every 8–10 hours |
|
|
|
|
|
congestion. |
|
|
|
|
|
|
|
|
|
|||||
|
Decongestants, |
|
Phenylephrine, 10 mg |
|
|
Novahistine Elixir, |
|
|
Oral decongestants have a |
|
|
|
systemic |
|
every 4 hours |
|
|
various generic |
|
|
prolonged duration of action |
|
|
|
|
|
|
|
|
combination products |
|
|
but may cause more systemic |
|
|
|
|
|
|
|
|
|
|
|
effects, including |
|
|
|
|
|
Pseudoephedrine, 60 |
|
|
Sudafed, various generic |
|
|
|||
|
|
|
mg every 4–6 hours or |
|
|
|
|
|
nervousness, excitability, |
|
|
|
|
|
|
|
|
|
|
restlessness, and insomnia. |
|
|
|
|
|
|
120 mg (extended |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Also available in |
|
|
|
|
|
|
release) every 12 hours |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
antihistamine, antitussive, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
expectorant, and analgesic |
|
|
|
|
|
|
|
|
|
|
|
combination products. |
|
|
|
|
|
|
|
|
|
|
|
Phenylephrine is |
|
|
|
|
|
|
|
|
|
|
|
unpredictably absorbed from |
|
|
|
|
|
|
|
|
|
|
|
the gastrointestinal tract. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expectorants |
|
Guaifenesin, 100–400 |
|
|
Robitussin, various |
|
|
The only OTC expectorant |
|
|
|
|
|
mg every 4 hours |
|
|
generic |
|
|
recognized as safe and |
|
|
|
|
|
|
|
|
|
|
|
effective by the FDA. Often |
|
|
|
|
|
|
|
|
|
|
|
used with antihistamines, |
|
|
|
|
|
|
|
|
|
|
|
decongestants, and |
|
|
|
|
|
|
|
|
|
|
|
antitussives in combination |
|
|
|
|
|
|
|
|
|
|
|
products. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hair growth |
|
Minoxidil, 2%, 5% |
|
|
Rogaine for Men, |
|
|
Minoxidil appears to directly |
|
|
|
stimulants |
|
solution, apply 1 mL to |
|
|
Rogaine for Women, |
|
|
stimulate hair follicles |
|
|
|
|
|
affected areas of scalp |
|
|
Rogaine Extra Strength |
|
|
resulting in increased hair |
|
|
|
|
|
twice daily. |
|
|
for Men |
|
|
thickness and reduced hair |
|
|
|
|
|
|
|
|
|
|
|
loss. Treatment for four |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
months or longer may be |
||
|
|
|
|
|
|
|
|
|
necessary to achieve visible |
||
|
|
|
|
|
|
|
|
|
results. If new hair growth is |
||
|
|
|
|
|
|
|
|
|
observed, continued |
||
|
|
|
|
|
|
|
|
|
treatment is necessary as hair |
||
|
|
|
|
|
|
|
|
|
density returns to |
||
|
|
|
|
|
|
|
|
|
pretreatment levels within |
||
|
|
|
|
|
|
|
|
|
months following drug |
||
|
|
|
|
|
|
|
|
|
discontinuation. |
||
|
Laxatives |
|
Bulk formers: |
|
|
Citrucel, Equalactin, |
|
|
The safest laxatives for |
|
|
|
|
|
Polycarbophil, |
|
|
Konsyl, Metamucil, |
|
|
chronic use include the bulk |
|
|
|
|
|
psyllium and |
|
|
Perdiem, various generic |
|
|
formers and stool softeners. |
|
|
|
|
|
methylcellulose |
|
|
|
|
|
Saline laxatives and |
|
|
|
|
|
preparations. Dosage |
|
|
|
|
|
stimulants may be used |
|
|
|
|
|
varies; consult product |
|
|
|
|
|
acutely but not chronically |
|
|
|
|
|
labeling |
|
|
|
|
|
(see text). Bulk formers hold |
|
|
|
|
|
|
|
|
|
|
|
water and expand in stool, |
|
|
|
|
|
|
|
|
|
|
|
promoting peristalsis. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stool softeners: |
|
|
Colace, Surfak, various |
|
|
Soften fecal material via |
|
|
|
|
|
Docusate sodium, 50– |
|
|
generic |
|
|
detergent action that allows |
|
|
|
|
|
500 mg daily. |
|
|
|
|
|
water to penetrate stool. |
|
|
|
|
|
Docusate calcium, 240 |
|
|
|
|
|
|
|
|
|
|
|
mg daily |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stimulant laxatives: |
|
|
Correctol, Dulcolax, Ex- |
|
|
Stimulant laxative actions |
|
|
|
|
|
Bisacodyl, 5–15 mg |
|
|
Lax, Senokot, various |
|
|
include direct irritation of |
|
|
|
|
|
daily. Senna: dosage |
|
|
generic |
|
|
intestinal mucosa or |
|
|
|
|
|
varies, consult product |
|
|
|
|
|
stimulation of the myenteric |
|
|
|
|
|
labeling |
|
|
|
|
|
plexus, resulting in |
|
|
|
|
|
|
|
|
|
|
|
peristalsis. These agents may |
|
|
|
|
|
|
|
|
|
|
|
also cause alteration of fluid |
|
|
|
|
|
|
|
|
|
|
|
and electrolyte absorption, |
|
|
|
|
|
|
|
|
|
|
|
resulting in luminal fluid |
|
|
|
|
|
|
|
|
|
|
|
accumulation and bowel |
|
|
|
|
|
|
|
|
|
|
|
evacuation. |
|
|
|
Pediculicides |
|
Permethrin 1% |
|
|
Nix |
|
|
Instructions for use varies; |
|
|
|
(head lice) |
|
|
|
|
|
|
|
consult product labeling. |
|
|
|
|
Pyrethrins (0.3%) |
|
|
A-200, RID |
|
|
|
|
||
|
|
|
|
|
|
|
Avoid contact with eyes. |
|
|
||
|
|
|
combined with |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comb out nits. Linens, |
|
|
|
|
|
|
piperonyl butoxide (3– |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
pajamas, combs, and brushes |
|
|
|
|
|
|
4%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
should be washed daily until |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
the infestation is eliminated. |
|
|
|
|
|
|
|
|
|
|
|
Repeat application 7 days |
|
|
|
|
|
|
|
|
|
|
|
later if live nits are still |
|
|
|
|
|
|
|
|
|
|
|
visible. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sleep aids |
|
Diphenhydramine, 25– |
|
|
Compoz, Nytol, |
|
|
Diphenhydramine and |
|
|
|
|
|
50 mg at bedtime |
|
|
Sominex, various generic |
|
|
doxylamine are |
|
|
|
|
|
|
|
|
|
|
|
|
|
|


patient is taking. Many of the more potent OTC ingredients are hidden in products where their presence would not ordinarily be expected (Table 64–3). While most OTC medications are clearly labeled with the specific ingredients contained in the product, many products do not presently conform to the new FDA-mandated standardized OTC medication labeling requirements that are being phased in through 2005. Lack of awareness of the ingredients present in OTC products and the belief by many physicians that OTC products are ineffective and harmless may cause diagnostic confusion and perhaps interfere with therapy. For example, innumerable OTC products, including analgesics and allergy, cough, and cold preparations, contain sympathomimetics. These agents should be avoided or used cautiously by type 1 diabetics and patients with hypertension, angina, or hyperthyroidism. Aspirin should not be used in children and adolescents for viral infections (with or without fever) because of an increased risk of Reye's syndrome. Aspirin and other NSAIDs should be avoided by individuals with active peptic ulcer disease, certain platelet disorders, and patients taking oral anticoagulants. Cimetidine, an H2-receptor antagonist, is a well-known inhibitor of hepatic drug metabolism and can increase the blood levels and toxicity of drugs such as phenytoin, theophylline, and warfarin.
Table 64–3. Hidden Ingredients in Over-the-Counter (OTC) Products.
Hidden Drug or Drug |
OTC Class Containing |
|
Product Examples |
|
Class |
Drug |
|
|
|
Alcohol (percent ethanol) |
Cough syrups, cold |
|
Cheracol Plus (5%) |
|
|
preparations |
|
Comtrex Multi-Symptom Cold & |
|
|
|
|
||
|
|
|
|
|
|
|
|
Cough Relief (10%) |
|
|
|
|
Vicks 44M (10%) |
|
|
|
|
|
|
|
|
|
Vicks NyQuil Liquid (10%) |
|
|
|
|
|
|
|
Mouthwashes |
|
Cepacol Mouthwash (14%) |
|
|
|
|
Listerine (27%) |
|
|
|
|
|
|
|
|
|
Scope (15%) |
|
|
|
|
|
|
Antihistamines |
Analgesics |
|
Aspirin Free Anacin PM |
|
|
|
|
Aspirin Free Excedrin PM |
|
|
|
|
|
|
|
|
|
Extra Strength Bayer PM |
|
|
|
|
|
|
|
|
|
Percogesic Extra Strength |
|
|
|
|
|
|
|
|
|
Tylenol PM |
|
|
|
|
|
|
|
|
|
Tylenol Severe Allergy |
|
|
|
|
|
|
|
Menstrual products |
|
Midol PM |
|
|
|
|
Maximum Strength Midol Menstrual |
|
|
|
|
|
|
|
|
|
Maximum Strength Midol PMS |
|
|
|
|
|
|
|
|
|
Maximum Strength Multi-Symptom |
|
|
|
|
|
|
|
|
|
Pamprin |
|
|
|
|
Menstrual Relief |
|
|
|
|
|
|
|
|
|
Premsyn PMS |
|
|
|
|
|
|
|
|
|
|
|
|
Sleep aids |
|
Compoz |
|
|
|
|
|
|
|
|
|
|
|
|
Nytol |
||
|
|
|
|
|
|
Sominex |
|
|
|
|
|
|
|
|
Twilite Caplets |
|
|
|
|
|
|
|
|
Unisom |
|
|
|
Aspirin and other |
|
Antidiarrheals |
|
|
Pepto-Bismol (bismuth subsalicylate) |
|
|
|
salicylates |
|
Cold/allergy preparations |
|
|
Alka-Seltzer Plus Cold & Cough |
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
Liqui-Gels |
|
|
|
|
|
|
|
|
BC Allergy Sinus Cold Powder |
|
|
|
Caffeine |
|
Analgesics |
|
|
Alka-Seltzer Morning Relief |
|
|
|
|
|
|
|
|
Anacin |
|
|
|
|
|
|
|
|
Cope |
|
|
|
|
|
|
|
|
Excedrin Extra Strength |
|
|
|
|
|
|
|
|
Excedrin Migraine |
|
|
|
|
|
|
|
|
Goody's Extra Strength Fast Relief |
|
|
|
|
|
|
|
|
Goody's Extra Strength Headache |
|
|
|
|
|
|
|
|
Powder |
|
|
|
|
|
|
|
|
Vanquish |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Menstrual products |
|
|
Maximum Strength Midol Menstrual |
|
|
|
|
|
Stimulants |
|
|
Lucidex |
|
|
|
|
|
|
|
|
NoDoz |
|
|
|
|
|
|
|
|
Vivarin |
|
|
|
Local anesthetics (usually |
|
Antitussives/Lozenges |
|
|
Cepacol Maxium Strength Lozenges |
|
|
|
benzocaine) |
|
|
|
|
Spec T Sore Throat/Cough |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Suppressant |
|
|
|
|
|
|
|
|
Vicks Chloraseptic Lozenges |
|
|
|
|
|
Dermatologic preparations |
|
|
Americaine |
|
|
|
|
|
|
|
|
Bactine |
|
|
|
|
|
|
|
|
Dermoplast |
|
|
|
|
|
|
|
|
Lanacane |
|
|
|
|
|
|
|
|
Solarcaine |
|
|
|
|
|
Hemorrhoidal products |
|
|
Americaine |
|
|
|
|
|
|
|
|
Anusol Ointment |
|
|
|
|
|
|
|
|
Medicone |
|
|
|
|
|
|
|
|
Tronolane |
|
|
|
|
|
Toothache, cold sore, and |
|
|
(Many) |
|
|
|
|
|
teething products |
|
|
Anbesol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Baby Orajel |
|
|
|
|
|
|
|
|
Kank-A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Orabase B |
||
|
|
|
|
|
|
|
Zilactin-B |
|
|
|
Sodium (mg/tablet or mg/5 |
|
|
Analgesics |
|
|
Alka-Seltzer Original Effervescent |
|
|
|
mL or as stated) |
|
|
|
|
|
Tablet (568) |
|
|
|
|
|
|
|
|
|
Alka-Seltzer Extra Strength |
|
|
|
|
|
|
|
|
|
Effervescent Tablet (588) |
|
|
|
|
|
|
|
|
|
Bromo-Seltzer Granules (959/pre- |
|
|
|
|
|
|
|
|
|
measured packet) |
|
|
|
|
|
|
Antacids |
|
|
Alka-Seltzer Original Effervescent |
|
|
|
|
|
|
|
|
|
Tablet (568) |
|
|
|
|
|
|
|
|
|
Alka-Seltzer Extra Strength |
|
|
|
|
|
|
|
|
|
Effervescent Tablet (588) |
|
|
|
|
|
|
|
|
|
Alka-Seltzer Gold (299) |
|
|
|
|
|
|
|
|
|
Alka-Seltzer Heartburn Relief (569) |
|
|
|
|
|
|
|
|
|
Bromo-Seltzer Granules (959/pre- |
|
|
|
|
|
|
|
|
|
measured packet) |
|
|
|
|
|
|
|
|
|
Citrocarbonate Effervescent Granules |
|
|
|
|
|
|
|
|
|
(780/ teaspoon) |
|
|
|
|
|
|
Laxatives |
|
|
Fleets Enema (4,439 mg, of which |
|
|
|
|
|
|
|
|
|
275–400 mg/enema is absorbed) |
|
|
|
|
|
|
|
|
|
Fleet Phospho-Soda (554/teaspoon) |
|
|
|
Sympathomimetics |
|
|
Analgesics |
|
|
Motrin Sinus Headache |
|
|
|
|
|
|
|
|
|
Sinarest No Drowsiness |
|
|
|
|
|
|
|
|
|
Sine-Aid Sinus Headache Tablets |
|
|
|
|
|
|
|
|
|
Sinutab |
|
|
|
|
|
|
|
|
|
Tylenol Flu Day Non-Drowsy |
|
|
|
|
|
|
|
|
|
Tylenol Sinus Day Non-Drowsy |
|
|
|
|
|
|
Asthma products |
|
|
Bronkaid Dual Action |
|
|
|
|
|
|
|
|
|
Primatene |
|
|
|
|
|
|
Cold/allergy preparations |
|
|
(Many) |
|
|
|
|
|
|
|
|
|
Advil Cold and Sinus |
|
|
|
|
|
|
|
|
|
Alka-Seltzer Plus |
|
|
|
|
|
|
|
|
|
Comtrex Maximum Strength Day and |
|
|
|
|
|
|
|
|
|
Night Flu |
|
|
|
|
|
|
|
|
|
Contac Severe Cold and Flu |
|
|
|
|
|
|
|
|
|
Dimetapp Cold & Allergy |
|
|
|
|
|
|
|
|
|
PediaCare Cold & Allergy |
|
|
|
|
|
|
|
|
|
Motrin Cold & Flu |
|
|
|
|
|
|
|
|
|
Sudafed |
|
|
|
|
|
|
|
|
|
TheraFlu Severe Cold & Congestion |
|
|
|
|
|
|
|
|
|
|
|
|

|
|
|
|
Triaminic Chest Congestion |
||
|
|
|
|
Vicks 44M |
|
|
|
|
|
|
Vicks DayQuil |
|
|
|
|
|
|
Vicks NyQuil |
|
|
|
Cough preparations |
|
|
(Many) |
|
|
|
|
|
|
PediaCare Long Lasting Cough Plus |
|
|
|
|
|
|
Cold |
|
|
|
|
|
|
Robitussin PM Cold & Cough |
|
|
|
|
|
|
Robitussin Maximum Strength |
|
|
|
|
|
|
Cough & Cold |
|
|
|
|
|
|
Triaminic Cough |
|
|
|
|
|
|
Vicks 44D |
|
|
|
Hemorrhoidal products |
|
|
Hem-Prep |
|
|
|
|
|
|
Pazo Hemorrhoid Ointment |
|
|
|
|
|
|
Preparation H |
|
|
|
|
|
|
|
|
|
|
Sore throat products |
|
|
Spec-T Sore Throat/Decongestant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Overuse or misuse of OTC products may induce significant medical problems. A prime example is rebound congestion from the regular use of decongestant nasal sprays for more than 3 days. The improper and chronic use of some antacids (eg, aluminum hydroxide) may cause constipation and even impaction in elderly people, as well as hypophosphatemia. Laxative abuse can result in abdominal cramping and fluid and electrolyte disturbances. Insomnia, nervousness, and restlessness can result from the use of sympathomimetics or caffeine hidden in many OTC products (Table 64– 3). The chronic systemic use of some analgesics containing large amounts of caffeine may produce rebound headaches, and long-term use of analgesics has been associated with interstitial nephritis. Recent evidence suggests that use of OTC products containing aspirin, other salicylates, acetaminophen, ibuprofen, naproxen, or ketoprofen may increase the risk of hepatotoxicity and gastrointestinal hemorrhage in individuals who consume three or more alcoholic drinks daily. Furthermore, acute ingestion of large amounts of aspirin or acetaminophen by adults or children can cause serious toxicity. Antihistamines may cause sedation or drowsiness, especially when taken concurrently with sedative-hypnotics, tranquilizers, alcohol, or other central nervous system depressants. Finally, antihistamines, local anesthetics, antimicrobial agents, counterirritants, p- aminobenzoic acid (PABA) and preservatives contained in a myriad of OTC topical and vaginal products may induce allergic reactions.
There are three major drug information sources for OTC products. Handbook of Nonprescription Drugs is the most comprehensive resource for OTC medications; it evaluates ingredients contained in major OTC drug classes and lists the ingredients included in many OTC products. Nonprescription Drug Therapy is a loose-leaf reference, updated quarterly, that provides detailed OTC product information and patient counseling instructions. Physicians' Desk Reference for Nonprescription Drugs, a compendium of manufacturers' information regarding OTC products, is published annually but is somewhat incomplete with regard to the number of products included and the consistency of information provided. Any health care provider who seeks more specific information regarding OTC products may find the references useful.
Chapter 65. Botanicals ("Herbal Medications") & Nutritional
Supplements
Botanicals ("Herbal Medications") & Nutritional Supplements: Introduction
The medical use of botanicals in their natural and unprocessed form undoubtedly began when the first intelligent animals noticed that certain food plants altered particular body functions. Much information exists about the historical use and effectiveness of botanical products. Unfortunately, the quality of this information is extremely variable. One of the most complete compendiums of clinical recommendations regarding the use of botanicals is the Report of the German Commission E (a committee that sets standards for herbal medications in that country; Blumenthal, 2000). Interest in the endocrine effects and possible nutritional benefits of certain purified chemicals such as dehydroepiandrosterone, melatonin, high-dose vitamins, and minerals has led to a parallel development of consumer demand for such substances. These substances, together with the botanicals, constitute a substantial source of profits for those who exploit the concept of "alternative medicine."
The alternative medicinal substances are distinguished from similar botanical substances used in traditional medicine (morphine, digitalis, atropine, etc) by virtue of being available without a prescription and, unlike over-the-counter medications, being legally considered dietary supplements rather than drugs (thus avoiding conventional FDA oversight). Among the purified chemicals, dehydroepiandrosterone and melatonin are of significant pharmacologic interest.
This chapter provides an evidence-based approach to the pharmacology and clinical efficacy of several of the commonly used and commercially available botanicals and dietary supplements. Ephedrine, the active principle in Ma-huang, is discussed in Chapter 9: Adrenoceptor-Activating & Other Sympathomimetic Drugs.
Regulatory Factors
Dietary supplements (which include vitamins, minerals, cofactors, herbal medications, and amino acids) are not considered over-the-counter drugs in the USA but rather food supplements. In 1994, the United States Congress, influenced by growing "consumerism" as well as strong manufacturer lobbying efforts, passed the Dietary Supplement and Health Education Act (DSHEA). This landmark act prevented adequate FDA oversight of these substances. Thus, DSHEA has allowed a variety of substances with pharmacologic activity—if classified as dietary supplements—to be sold without a prescription or any FDA review of efficacy or safety prior to product marketing. Dietary supplements are governed under Current Good Manufacturing Practice in Manufacturing, Packaging or Holding Human Food (CGMP) regulations. Although administered by the FDA, CGMP regulations are often inadequate to ensure product purity, potency, and other variables such as accurate product identification and appropriate botanical harvesting. Therefore, much of the criticism regarding the dietary supplement industry involves a lack of product purity and variations in potency.
In 1999, the FDA announced labeling recommendations for dietary supplements marketed in the USA. These recommendations were not mandated; some manufacturers, however, have adopted them in an effort to increase sales. According to these recommendations, the term "dietary